Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3/FCRL6 engagement.
暂无分享，去创建一个
S. Loi | J. Kim | J. Sosman | J. Bordeaux | D. Rimm | R. Salgado | Douglas B. Johnson | J. Balko | M. V. Estrada | M. Sanders | Yaomin Xu | Yu Wang | L. Horn | V. Sanchez | P. Ferrell | S. Opalenik | Daniel Y Wang | E. Castellanos | Mellissa J. Nixon | R. Davis | Phillip T. Dean | D. Schreeder | Paula I. Ericsson-Gonzalez | Candace H. Cote | Douglas B. Johnson | P. Ericsson-Gonzalez | Daniel Y. Wang | Ju Young Kim | P. Brent Ferrell | Randall S. Davis | P. B. Ferrell